Voya Investment Management LLC Has $12.27 Million Stock Position in The Clorox Company (NYSE:CLX)

Voya Investment Management LLC lessened its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 5.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 75,538 shares of the company’s stock after selling 4,493 shares during the quarter. Voya Investment Management LLC’s holdings in Clorox were worth $12,268,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in CLX. Brooklyn Investment Group increased its holdings in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Clorox during the 4th quarter worth approximately $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox during the 4th quarter worth approximately $31,000. Asset Planning Inc bought a new stake in Clorox in the 4th quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. bought a new stake in Clorox in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock opened at $138.86 on Tuesday. The firm has a 50-day moving average of $145.37 and a 200-day moving average of $155.48. The company has a market cap of $17.11 billion, a P/E ratio of 37.94, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company earned $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.51%. Clorox’s dividend payout ratio is presently 133.33%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CLX. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. UBS Group dropped their price objective on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Wells Fargo & Company dropped their target price on Clorox from $155.00 to $145.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 16th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating on the stock in a research report on Friday, April 11th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $153.83.

Read Our Latest Report on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.